Larry W. Papasan, Director at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 7,400 shares at $2.34 ($17K) on 2012-03-27, disclosed to the SEC on 2012-03-29.
Open-market purchase of $17k BMTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.32 | 2,000 | $5K | 27.0% |
| 2 | $2.32 | 3,000 | $7K | 40.4% |
| 3 | $2.34 | 2,400 | $6K | 32.6% |
| Total | $2.33 avg | 7,400 | $17K | 100% |
| Filing → |
| BMTI | SELL | 2011-06-14 | $37K | — | Filing → |
| UTG | SELL | 2010-10-28 | $21K | — | Filing → |
| MDXG.OB | BUY | 2009-11-20 | $25K | — | Filing → |